Reference field note
Liraglutide
A reference record with its source links, an editorial reading note, and questions to carry forward.
Aliases: Saxenda
- Status
- Approved product
- Evidence label
- Randomized evidence
- Index topics
- Metabolism
- Status as of
The record
Recorded fields
- Mechanism
- Activates the GLP-1 receptor.
- Evidence
- Randomized trials.
- Limitations
- Check other products separately.
- Safety
- The label warns about severe gastrointestinal reactions.
- Route context
- Subcutaneous injection.
- Approval scope
- Saxenda: weight management for eligible patients.
Pause and consider
A reading note
An unfamiliar expression can make an entire passage feel inaccessible. Set it aside briefly and describe the surrounding question in ordinary language. Then seek a definition that fits the expression as used in that passage, rather than accepting any familiar meaning of the word. Put the definition back into the sentence and see whether the argument becomes understandable. This checks comprehension; it does not settle whether the argument is convincing. Keeping those tasks separate makes it possible to ask for help with vocabulary without losing the larger question you wanted to examine.
Questions to carry forward
- What question is this passage addressing before I try to define its unfamiliar expression?
- Does the definition fit how the expression is used in this sentence?
- After replacing the expression with ordinary language, what reasoning still needs examination?
Follow the record
References
- SAXENDA
NLM · Checked
Prepared by the Panda Bear editorial team. Educational information; no independent medical review is claimed.